Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 34Esophageal Neoplasms 19Pancreatic Neoplasms 9Esophageal Squamous Cell Carcinoma 6Stomach Neoplasms 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 3Resectable Esophageal Cancer 2Pathologic Complete Response 2Neoplasms by Site 2Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Thrombocytopenia 1Rectal Malignant Neoplasms 1Rectal Diseases 1Radiation Injuries 1Postoperative Complications 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pancreatic Cancer Non-resectable 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Histologic Type 1Margins of Excision 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Locally Advanced Rectal Cancer 1

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Neoadjuvant Therapy 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer × Chemoradiotherapy × Gastrointestinal × Clear all
NCT04423965 2021-03-23

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown
220 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡